Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic Hematopoietic Stem Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07297173
What this trial is testing

Phase 1 Study of Chemotherapy Plus HLA-mismatched GPBMC Infusion Bridging to Allo-HSCT for R/R Leukemia

Who this might be right for
Relapsed LeukemiaRefractory Leukemia
Beijing 302 Hospital 5
Early research (Phase 1)Ended earlyNCT04203017
What this trial is testing

Fecal Microbiota Transplantation After Autologous HSCT in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
St. Petersburg State Pavlov Medical University 20
Not applicableLooking for participantsNCT06003660
What this trial is testing

Oral, Chemosensory and Trigeminal Functions in Allo-HSCT

Who this might be right for
Hematopoietic Stem Cell Transplantation
University of Oslo 70
Testing effectiveness (Phase 2)UnknownNCT06247917
What this trial is testing

Evaluate the Efficacy and Safety of Allogeneic Haematopoietic Stem Cell Transplantation With FBM Conditioning for MDS

Who this might be right for
Myelodysplastic Syndrome With Excess Blasts-1Myelodysplastic Syndrome With Excess Blasts-2Myelodysplastic Syndromes
Ruijin Hospital 59
Not applicableStudy completedNCT03575767
What this trial is testing

Characteristics and Dynamics of TCR Repertoire in Patients With Hematological Malignancies After Allo-HSCT

Who this might be right for
Hematologic NeoplasmsHematopoietic Stem Cell TransplantationGraft Vs Host Disease+1 more
Affiliated Hospital to Academy of Military Medical Sciences 30
Not applicableStudy completedNCT00281801
What this trial is testing

Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
Case Comprehensive Cancer Center 168
Not applicableUnknownNCT06075212
What this trial is testing

Immune Reconstitution After Allo-HSCT and Blinatumomab

Who this might be right for
Leukemia, Lymphoid
Sichuan University 20
Not applicableLooking for participantsNCT06208137
What this trial is testing

Using the Composite Immune Risk Score to Assess and Modulate the Patient's Post-transplant Immune Reconstitution.

Who this might be right for
Transplant-Related Disorder
Institute of Hematology & Blood Diseases Hospital, China 456
Testing effectiveness (Phase 2)Looking for participantsNCT06938867
What this trial is testing

Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-Transplant

Who this might be right for
E Coli InfectionsAllogenic Transplant Patients
SNIPR Biome Aps. 24
Not applicableUnknownNCT03659084
What this trial is testing

Study of the Outcome of Patients With Acute Myeloblastic Leukemia and Myelodysplastic Syndrome Receiving Iron Chelation Therapy After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Myeloid LeukemiaMyelodysplastic Syndromes
Hospices Civils de Lyon 150
Testing effectiveness (Phase 2)Study completedNCT05090384
What this trial is testing

Pediatric GVHD Low Risk Steroid Taper Trial

Who this might be right for
Acute Graft vs Host DiseaseAllogeneic Bone Marrow TransplantationAdverse Effects
John Levine 50
Not applicableNot Yet RecruitingNCT06758726
What this trial is testing

Mitoxantrone Hydrochloride Liposome Combined With BU/Cy Were Used as a Conditioning Regimen for Patients With Intermediate/Adverse Risk or Persistently Positive MRD AML

Who this might be right for
AML
Institute of Hematology & Blood Diseases Hospital, China 20
Early research (Phase 1)Active Not RecruitingNCT04098393
What this trial is testing

Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation

Who this might be right for
Hematologic Malignancies
Memorial Sloan Kettering Cancer Center 39
Testing effectiveness (Phase 2)Study completedNCT01818284
What this trial is testing

Plerixafor for Stem Cell Mobilization in Normal Donors

Who this might be right for
Blood And Marrow Transplantation
M.D. Anderson Cancer Center 22
Large-scale testing (Phase 3)Study completedNCT04167514
What this trial is testing

Treatment of GVHD in Hematopoietic Stem Cell Transplant (HSCT) Recipients Using AAT Plus Corticosteroids (CS) Compared With Corticosteroids Alone

Who this might be right for
Graft Versus Host Disease (GVHD)
CSL Behring 136
Early research (Phase 1)Active Not RecruitingNCT05015426
What this trial is testing

Gamma Delta T-cell Infusion for AML at High Risk of Relapse After Allo HCT

Who this might be right for
Acute Myeloid Leukemia
H. Lee Moffitt Cancer Center and Research Institute 20
Testing effectiveness (Phase 2)Study completedNCT00823316
What this trial is testing

Safety and Efficacy Study of Umbilical Cord Blood-Drived Mesenchymal Stem Cells to Promote Engraftment of Unrelated Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Leukemia
Medipost Co Ltd. 10
Very early researchUnknownNCT04626726
What this trial is testing

Adult B-ALL Treated by CART Cell Bridging Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Adult B Acute Lymphoblastic Leukemia
Hebei Senlang Biotechnology Inc., Ltd. 50
Not applicableStudy completedNCT00167167
What this trial is testing

Donor Lymphocyte Infusion (DLI) for Relapsed (Post Transplant) Leukemia

Who this might be right for
Leukemia, Myeloid, ChronicAMLMDS+1 more
Masonic Cancer Center, University of Minnesota 40
Not applicableStudy completedNCT04399863
What this trial is testing

ETOILE : A Feasibility Study in Pediatric Patient Education

Who this might be right for
Leukemia, Lymphoblastic
Assistance Publique - Hôpitaux de Paris 10
Next Page